Dr. Martin Brenner, CEO & Chief Scientific Officer of iBio, talks to our hosts about obesity treatments, biotechnology innovation, and the development of next-generation therapeutics.
February 7, 2023
Dr. Martin Brenner, CEO & Chief Scientific Officer of iBio, talks to our hosts about obesity treatments, biotechnology innovation, and the development of next-generation therapeutics.
Other Interviews
